Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
As far as
, they have a huge problem with Jakafi. For details, look at youtube video by Dr. Pardanani, who is @ Mayo.
Jakafi is a terrible drug for MF and should not have been approved by the FDA. This makes other indications for Jakafi very questionable.
Add a reply...
Latest StockTalks »
people get INCY breaking news and analysis by email alert.
Get email alerts on INCY »
Get latest price
From other sites
Commit To Purchase Incyte Corporation At $67.50, Earn 7% Annualized Using Options
at Nasdaq.com (Mar 11, 2015)
10 Biotech Stories You Might've Missed This Week
at Benzinga.com (Jan 15, 2015)
Health care's strong 2015 outlook
at CNBC.com (Jan 13, 2015)
Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1
at Benzinga.com (Jan 12, 2015)
Cramer Remix: Last chance to buy this stock
at CNBC.com (Jan 9, 2015)
Xignite quote data
© 2015 Seeking Alpha